Armo Biosciences, Inc.
Records under this name other than the patents Armo Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 6 of 6 · Back to Armo Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,814,679 | Interleukin-10 Production of Antigen-Specific CD8+ T Cells and Methods of Use of Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,413,332 | Methods of Using Interleukin-10 for Treating Diseases and Disorders Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,350,270 | Interleukin-15 compositions and uses thereof Lapsed on the fee record Ended Jul 16, 2023 · USPTO record | Lapsed on the fee record | Ended Jul 16, 2023 | USPTO record |
| US 10,010,588 | Methods of using pegylated interleukin-10 for treating hyperlipidemia Lapsed on the fee record Ended Jul 3, 2022 · USPTO record | Lapsed on the fee record | Ended Jul 3, 2022 | USPTO record |
| US 6,387,364 | Methods of healing wounds and fibrotic disorders using IL-10 Term ended Term ended May 1, 2020 · USPTO record | Term ended | Term ended May 1, 2020 | USPTO record |
| US 7,052,684 | Methods of healing wounds and fibrotic disorders using IL-10 Lapsed on the fee record Ended May 30, 2018 · USPTO record | Lapsed on the fee record | Ended May 30, 2018 | USPTO record |